Amy Gibson

UNSW Sydney — Australia

Medicine · Health Sciences

20h-index1.3kcitations69works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Opioid Use Disorder Treatment(22), Substance Abuse Treatment and Outcomes(18), Bioinformatics and Genomic Networks(10), Race, History, and American Society(9), Computational Drug Discovery Methods(8)

Publications69 total

Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia
International Journal of Epidemiology·2025· 3 citedOpen Access
The Impact of Severe Mental Illness on Treatment Retention and All-Cause Mortality of Individuals in Opioid Agonist Treatment: A Retrospective Data Linkage Study
Drug and Alcohol Dependence·2025
Table S5 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Data from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Data from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S3 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Supplementary Methods from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S1 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S2 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S3 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S5 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S4 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S2 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S4 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Supplementary Methods from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Figure S1- S8 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Table S1 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Figure S1- S8 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023Open Access
Diver Communication and Localization System using Underwater Acoustics
Global Oceans 2020: Singapore – U.S. Gulf Coast·2020· 7 cited
Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort
The Pediatric Infectious Disease Journal·2019· 7 cited
page 1 of 4Next →

Frequent Co-authors

Louisa Degenhardt(20), Sarah Larney(9), Jo Kimber(7), Natasa Gisev(7), Lucy Burns(7), Barrie Peck(7), P. A. Bland(7), Ioanna Mavrommati(7), Gareth Muirhead(7), Hannah Cottom(7), Patty T. Wai(7), Sarah Maguire(7), Holly E. Barker(7), Eamonn Morrison(7), Divya Kriplani(7), Lu Yu(7), Giulia Falgari(7), Keith Brennan(7), Gillian Farnie(7), Richard Buus(7)